THERALASE TECHNOLOGIES INC /FI research brief

CIK 923883 Copy CIK

Generated Nov. 12, 2026, 1:32 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: Toronto A6. Reported legal jurisdiction: ONTARIO, CANADA. These do not establish investor residence or where funds were deployed.

• Aug. 31, 2026 · D · 0001062993-26-004733 · Source evidence

  Reported offering amount: 168695 USD. Reported amount sold: 72298 USD.

• May 27, 2026 · D · 0001062993-26-002887 · Source evidence

  Reported offering amount: 262156 USD. Reported amount sold: 109080 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “THERALASE TECHNOLOGIES INC /FI research brief,” CIK 923883, retrieved Nov. 12, 2026, 1:32 a.m.. Cite the specific accessions used. No amounts have been summed.